FULGENT GENETICS, INC. (FLGT) Debt Components
- 2026-06-30: Notes Payable, CurrentUSD $482.00K.
- 2026-03-31: Notes Payable, CurrentUSD $482.00K.
- 2025-12-31: Notes Payable, CurrentUSD $476.00K.
- 2025-09-30: Notes Payable, CurrentUSD $476.00K.
FULGENT GENETICS, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Notes Payable, Current USD |
|---|---|
| 2026-06-30 | $482.00K |
| 2026-03-31 | $482.00K |
| 2025-12-31 | $476.00K |
| 2025-09-30 | $476.00K |
| 2025-06-30 | $476.00K |
| 2025-03-31 | $476.00K |
| 2024-12-31 | $412.00K |
| 2024-09-30 | $412.00K |
| 2024-06-30 | $412.00K |
| 2024-03-31 | $413.00K |
| 2023-12-31 | $1.18M |
| 2023-09-30 | $2.89M |
| 2023-06-30 | $4.56M |
| 2023-03-31 | $5.61M |
| 2022-12-31 | $5.64M |
| 2022-09-30 | $5.48M |
| 2022-06-30 | $5.79M |
| 2022-03-31 | $6.09M |
| 2021-12-31 | $6.15M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |